alexa Acute lymphocytic leukemia | Belgium| PDF | PPT| Case Reports | Symptoms | Treatment

OMICS International organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Recommended Conferences

Relevant Topics

Acute Lymphocytic Leukemia

  • Share this page
  • Facebook
  • Twitter
  • LinkedIn
  • Google+
  • Pinterest
  • Blogger
  • Acute lymphocytic leukemia

     Acute lymphoblastic leukemia, also known as acute lymphocytic leukemia or acute lymphoid leukemia (ALL), is an acute form ofleukemia, or cancer of the white blood cells, characterized by the overproduction and accumulation of cancerous, immature white blood cells, known as lymphoblasts.

    Typical symptoms 

    • Generalized weakness and fatigue, Anemia, Dizziness, Frequent or unexplained fever and infection, Weight loss and/or loss of appetite, Excessive and unexplained bruising, Bone pain, joint pain (caused by the spread of "blast" cells to the surface of the bone or into the joint from the marrow cavity), Breathlessness, Enlarged lymph nodes, liver and/or spleen, Pitting edema (swelling) in the lower limbs and/or abdomen, Petechiae, which are tiny red spots or lines in the skin due to low platelet levels.


  • Acute lymphocytic leukemia

     Treatment and Medication

    Chemotherapy, Remission induction, Consolidation, Maintenance therapy, Immunotherapy, Biological therapy, Radiation therapy.

  • Acute lymphocytic leukemia


    Leukaemia describes a number of diseases of differing aetiology and clinical course. The four main subtypes are chronic lymphocytic leukaemia (CLL), chronic myeloid leukaemia (CML), acute lymphocytic leukaemia (ALL) and acute myeloid leukaemia (AML). The commonest of these (about 40% of all cases) is CLL (National Cancer Registry, 2010a). All leukaemias combined formed the tenth most common cancer in Ireland, accounting for 2.4% of all malignant neoplasms, excluding non-melanoma skin cancer, in women and 3.2% in men. The risk of developing leukaemia up to the age of 74 was 1 in 170 for women and 1 in 98 for men and was higher in RoI than in NI. At the end of 2008, 847 women and 1,196 men aged under 65, and 663 women and 924 men aged 65 and over, were alive up to 15 years after their leukaemia diagnosis.

Expert PPTs

Speaker PPTs


High Impact List of Articles

Conference Proceedings